Israel is arguably the epicenter of the medical cannabis world.
Raphael Mechoulam, the grandfather of modern cannabis and endocannabinoid system science, calls this country home. Israel has long been an example for the world on how to conduct real medical cannabis research.
All that research has provided solid footing for the country’s medical cannabis program, with today over 23,000 registered patients.
Shockingly, only 36 doctors have been approved to sign up qualified patients. Recognizing the need to make medical cannabis more accessible, Israeli government officials have approved 100 new doctors to register medical cannabis patients.
The majority of the current 36 doctors specialize in cancer, also known as oncologists. Allowing other types of doctors to prescribe medical cannabis would allow more than just a majority of cancer patients access to the program.
Obviously, medical cannabis is useful in treating a wide range of diseases and ailments like chronic pain and age-related degenerative diseases, and this new wider accessibility will hopefully serve new patient segments.
Israel is leading the world in a new factual science-based re-understanding of ‘pot’ as medical cannabis. They are positioned to potentially outpace the United States as the top supplier of what is soon to be the world’s best-known medicine as they continue to remove restrictions and allow growth.
Do you think Israel is taking it too slow in expanding their program, or going too fast? Tell us what you think in the comments below or on Facebook!